volume 6, issue 1, P37-44 2013
DOI: 10.15283/ijsc.2013.6.1.37
View full text
|
Sign up to set email alerts
|
Share

Abstract: This phase I study demonstrates that intramuscular hUCB-MSC injection is a safe and well tolerated treatment for patients with end-stage CLI due to ASO and TAO.

Search citation statements

Order By: Relevance

Citation Types

0
17
0
1

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals